Form 4 for TRAW Traws Pharma, Inc.
Accepted 2022-08-04 00:00:00 ET · period of report 2022-08-02 · accession 0001415889-22-008261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-04 | 2022-08-02 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | — | +4,750 | 14.4K | +49% | — |
| D | 2022-08-04 | 2022-08-03 | TRAW | Guerin Mark Patrick | CFO AND COO | F - Tax | $1.32 | -1,355 | 13.1K | -9% | -$1,789 |
| D | 2022-08-04 | 2022-08-02 | TRAW | Guerin Mark Patrick | CFO AND COO | M - OptEx | $0.00 | -4,750 | 9,500 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-02 | M | A | 4,750 | — | 14,431 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2022-08-03 | F | D | 1,355 | $1.32 | 13,076 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-08-02 | M | D | 4,750 | $0.00 | 9,500 | D | — · — to — | 4,750 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. |